TP53 c.481G>T ;(p.A161S)

Variant ID: 17-7578449-C-A

NM_000546.5(TP53):c.481G>T;(p.A161S)

This variant was identified in 63 publications

View GRCh38 version.




Publications:


Pan-cancer clinical impact of latent drivers from double mutations.

Communications Biology
Yavuz, Bengi Ruken BR; Tsai, Chung-Jung CJ; Nussinov, Ruth R; Tuncbag, Nurcan N
Publication Date: 2023-02-20

Variant appearance in text: TP53: A161S
PubMed Link: 36808143
Variant Present in the following documents:
  • 42003_2023_4519_MOESM3_ESM.xlsx, sheet 3
View BVdb publication page



Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.

Nature Communications
Hong, Lingzhi L; Aminu, Muhammad M; Li, Shenduo S; Lu, Xuetao X; Petranovic, Milena M; Saad, Maliazurina B MB; Chen, Pingjun P; Qin, Kang K; Varghese, Susan S; Rinsurongkawong, Waree W; Rinsurongkawong, Vadeerat V; Spelman, Amy A; Elamin, Yasir Y YY; Negrao, Marcelo V MV; Skoulidis, Ferdinandos F; Gay, Carl M CM; Cascone, Tina T; Gandhi, Saumil J SJ; Lin, Steven H SH; Lee, Percy P PP; Carter, Brett W BW; Wu, Carol C CC; Antonoff, Mara B MB; Sepesi, Boris B; Lewis, Jeff J; Gibbons, Don L DL; Vaporciyan, Ara A AA; Le, Xiuning X; Jack Lee, J J; Roy-Chowdhuri, Sinchita S; Routbort, Mark J MJ; Gainor, Justin F JF; Heymach, John V JV; Lou, Yanyan Y; Wu, Jia J; Zhang, Jianjun J; Vokes, Natalie I NI
Publication Date: 2023-02-08

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 36755027
Variant Present in the following documents:
  • 41467_2023_36328_MOESM7_ESM.xlsx, sheet 1
  • 41467_2023_36328_MOESM6_ESM.xlsx, sheet 1
View BVdb publication page



Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC).

Oncotarget
Alam, Md Maksudul MM; Fermin, Janmaris Marin JM; Knackstedt, Mark M; Noonan, Mackenzie J MJ; Powell, Taylor T; Goodreau, Landon L; Daniel, Emily K EK; Rong, Xiaohua X; Moore-Medlin, Tara T; Khandelwal, Alok R AR; Nathan, Cherie-Ann O CO
Publication Date: 2023-02-02

Variant appearance in text: TP53: A161S
PubMed Link: 36745547
Variant Present in the following documents:
  • Main text
  • oncotarget-14-28355.pdf
View BVdb publication page



Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications
Boström, Martin M; Larsson, Erik E
Publication Date: 2022-11-17

Variant appearance in text: TP53: A161S
PubMed Link: 36396655
Variant Present in the following documents:
  • 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China.

Bmc Medical Genomics
Liu, Jing J; Li, Zirong Z; Lu, Ting T; Pan, Junping J; Li, Li L; Song, Yanwen Y; Hu, Dan D; Zhuo, Yanhong Y; Chen, Ying Y; Xu, Qin Q
Publication Date: 2022-11-04

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 36333792
Variant Present in the following documents:
  • 12920_2022_1376_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page



Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.

Frontiers In Immunology
Liu, Zhichao Z; Lin, Guo G; Yan, Zeping Z; Li, Linduo L; Wu, Xingchen X; Shi, Jingrong J; He, Jianxing J; Zhao, Lei L; Liang, Hengrui H; Wang, Wei W
Publication Date: 2022

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 36238300
Variant Present in the following documents:
  • Table_1.xlsx, sheet 4
View BVdb publication page



EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.

Bmc Pulmonary Medicine
Li, Zhenxiang Z; Zhou, Qing Q; Wang, Qi Q; Wang, Haiyong H; Yue, Weiming W
Publication Date: 2022-09-19

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 36123678
Variant Present in the following documents:
  • 12890_2022_2161_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



CTCF DNA-binding domain undergoes dynamic and selective protein-protein interactions.

Iscience
Zhou, Rong R; Tian, Kai K; Huang, Jie J; Duan, Wenjia W; Fu, Hongye H; Feng, Ying Y; Wang, Hui H; Jiang, Yongpeng Y; Li, Yuanjun Y; Wang, Rui R; Hu, Jiazhi J; Ma, Hanhui H; Qi, Zhi Z; Ji, Xiong X
Publication Date: 2022-09-16

Variant appearance in text: p53: 481G>T
PubMed Link: 36117989
Variant Present in the following documents:
  • mmc4.xlsx, sheet 1
View BVdb publication page



Integrated cohort of esophageal squamous cell cancer reveals genomic features underlying clinical characteristics.

Nature Communications
Li, Minghao M; Zhang, Zicheng Z; Wang, Qianrong Q; Yi, Yan Y; Li, Baosheng B
Publication Date: 2022-09-07

Variant appearance in text: TP53: A161S
PubMed Link: 36071046
Variant Present in the following documents:
  • 41467_2022_32962_MOESM15_ESM.xlsx, sheet 22
View BVdb publication page



Landscape of somatic alterations in large-scale solid tumors from an Asian population.

Nature Communications
Wu, Liqun L; Yao, Herui H; Chen, Hui H; Wang, Aodi A; Guo, Kun K; Gou, Wenli W; Yu, Yanfei Y; Li, Xiang X; Yao, Ming M; Yuan, Shaohua S; Pang, Fei F; Hu, Jinwei J; Chen, Lijuan L; Liu, Wenjin W; Yao, Jicheng J; Zhang, Shuirong S; Dong, Xiaowei X; Wang, Weifeng W; Hu, Jing J; Ling, Qi Q; Ding, Songming S; Wei, Yan Y; Li, Qiang Q; Cao, Weichun W; Wang, Shuang S; Di, Yang Y; Feng, Feiling F; Zhao, Gang G; Zhang, Jian J; Huang, Ling L; Xu, Jia J; Yan, Wangjun W; Tong, Zhongsheng Z; Jiang, Da D; Ji, Tao T; Li, Qiao Q; Xu, Ling L; He, Huiying H; Shang, Liang L; Liu, Jin J; Wang, Kefeng K; Wu, Duoguang D; Shen, Jingnan J; Liu, Ye Y; Zhang, Ting T; Liang, Chaojie C; Wang, Yusheng Y; Shang, Yanhong Y; Guo, Jianji J; Liang, Guanbiao G; Xu, Shifeng S; Liu, Junfeng J; Wang, Kai K; Wang, Minghui M
Publication Date: 2022-07-23

Variant appearance in text: TP53: A161S
PubMed Link: 35871175
Variant Present in the following documents:
  • 41467_2022_31780_MOESM6_ESM.xlsx, sheet 1
View BVdb publication page



Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study.

Frontiers In Oncology
Shen, Fangfang F; Liang, Naixin N; Fan, Zaiwen Z; Zhao, Min M; Kang, Jing J; Wang, Xifang X; Hu, Qun Q; Mu, Yongping Y; Wang, Kai K; Yuan, Mingming M; Chen, Rongrong R; Guo, Wei W; Dong, Guilan G; Zhao, Jun J; Bai, Jun J
Publication Date: 2022

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 35814426
Variant Present in the following documents:
  • DataSheet_1.xlsx, sheet 2
View BVdb publication page



Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition.

Frontiers In Molecular Biosciences
Semenov, Oleg O; Daks, Alexandra A; Fedorova, Olga O; Shuvalov, Oleg O; Barlev, Nickolai A NA
Publication Date: 2022

Variant appearance in text: p53: A161S
PubMed Link: 35813818
Variant Present in the following documents:
  • Main text
  • fmolb-09-928399.pdf
View BVdb publication page



Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.

Aging
Su, Xiaofan X; Jin, Haoxuan H; Wang, Jiaqian J; Lu, Huiping H; Gu, Tiantian T; Gao, Zhibo Z; Li, Manxiang M
Publication Date: 2022-05-25

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 35613927
Variant Present in the following documents:
  • aging-14-204101-s004.xlsx, sheet 1
View BVdb publication page



Targeting tumor innervation: premises, promises, and challenges.

Cell Death Discovery
Li, Xinyu X; Peng, Xueqiang X; Yang, Shuo S; Wei, Shibo S; Fan, Qing Q; Liu, Jingang J; Yang, Liang L; Li, Hangyu H
Publication Date: 2022-03-25

Variant appearance in text: p53: A161s
PubMed Link: 35338118
Variant Present in the following documents:
  • Main text
View BVdb publication page



Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Publication Date: 2021

Variant appearance in text: TP53: A161S
PubMed Link: 34630336
Variant Present in the following documents:
  • Table_1.xlsx, sheet 2
View BVdb publication page



PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer.

Journal For Immunotherapy Of Cancer
Stein, Alexander A; Simnica, Donjete D; Schultheiß, Christoph C; Scholz, Rebekka R; Tintelnot, Joseph J; Gökkurt, Eray E; von Wenserski, Lisa L; Willscher, Edith E; Paschold, Lisa L; Sauer, Markus M; Lorenzen, Sylvie S; Riera-Knorrenschild, Jorge J; Depenbusch, Reinhard R; Ettrich, Thomas J TJ; Dörfel, Steffen S; Al-Batran, Salah-Eddin SE; Karthaus, Meinolf M; Pelzer, Uwe U; Waberer, Lisa L; Hinke, Axel A; Bauer, Marcus M; Massa, Chiara C; Seliger, Barbara B; Wickenhauser, Claudia C; Bokemeyer, Carsten C; Hegewisch-Becker, Susanna S; Binder, Mascha M
Publication Date: 2021-07

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 34315821
Variant Present in the following documents:
  • jitc-2021-002844supp002.xlsx, sheet 1
View BVdb publication page



A computational and structural analysis of germline and somatic variants affecting the DDR mechanism, and their impact on human diseases.

Scientific Reports
Magraner-Pardo, Lorena L; Laskowski, Roman A RA; Pons, Tirso T; Thornton, Janet M JM
Publication Date: 2021-07-12

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 34253785
Variant Present in the following documents:
  • 41598_2021_93715_MOESM2_ESM.xlsx, sheet 10
  • 41598_2021_93715_MOESM2_ESM.xlsx, sheet 9
View BVdb publication page



Profiling of 520 Candidate Genes in 50 Surgically Treated Chinese Small Cell Lung Cancer Patients.

Frontiers In Oncology
Yuan, Ting T; Wang, Xin X; Sun, Sijin S; Cao, Zheng Z; Feng, Xiaoli X; Gao, Yibo Y
Publication Date: 2021

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 34168983
Variant Present in the following documents:
  • DataSheet_2.xlsx, sheet 3
View BVdb publication page



Improvement of Neoantigen Identification Through Convolution Neural Network.

Frontiers In Immunology
Hao, Qing Q; Wei, Ping P; Shu, Yang Y; Zhang, Yi-Guan YG; Xu, Heng H; Zhao, Jun-Ning JN
Publication Date: 2021

Variant appearance in text: TP53: A161S
PubMed Link: 34113354
Variant Present in the following documents:
  • Table_1.xlsx, sheet 18
  • Table_1.xlsx, sheet 2
View BVdb publication page



Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients.

Genome Medicine
Tsui, Dana W Y DWY; Cheng, Michael L ML; Shady, Maha M; Yang, Julie L JL; Stephens, Dennis D; Won, Helen H; Srinivasan, Preethi P; Huberman, Kety K; Meng, Fanli F; Jing, Xiaohong X; Patel, Juber J; Hasan, Maysun M; Johnson, Ian I; Gedvilaite, Erika E; Houck-Loomis, Brian B; Socci, Nicholas D ND; Selcuklu, S Duygu SD; Seshan, Venkatraman E VE; Zhang, Hongxin H; Chakravarty, Debyani D; Zehir, Ahmet A; Benayed, Ryma R; Arcila, Maria M; Ladanyi, Marc M; Funt, Samuel A SA; Feldman, Darren R DR; Li, Bob T BT; Razavi, Pedram P; Rosenberg, Jonathan J; Bajorin, Dean D; Iyer, Gopa G; Abida, Wassim W; Scher, Howard I HI; Rathkopf, Dana D; Viale, Agnes A; Berger, Michael F MF; Solit, David B DB
Publication Date: 2021-05-31

Variant appearance in text: TP53: A161S
PubMed Link: 34059130
Variant Present in the following documents:
  • 13073_2021_898_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Spatially interacting phosphorylation sites and mutations in cancer.

Nature Communications
Huang, Kuan-Lin KL; Scott, Adam D AD; Zhou, Daniel Cui DC; Wang, Liang-Bo LB; Weerasinghe, Amila A; Elmas, Abdulkadir A; Liu, Ruiyang R; Wu, Yige Y; Wendl, Michael C MC; Wyczalkowski, Matthew A MA; Baral, Jessika J; Sengupta, Sohini S; Lai, Chin-Wen CW; Ruggles, Kelly K; Payne, Samuel H SH; Raphael, Benjamin B; Fenyö, David D; Chen, Ken K; Mills, Gordon G; Ding, Li L
Publication Date: 2021-04-19

Variant appearance in text: TP53: A161S
PubMed Link: 33875650
Variant Present in the following documents:
  • 41467_2021_22481_MOESM4_ESM.xlsx, sheet 6
  • 41467_2021_22481_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.

Nature Communications
Zhang, Yongliang Y; Yao, Yu Y; Xu, Yaping Y; Li, Lifeng L; Gong, Yan Y; Zhang, Kai K; Zhang, Meng M; Guan, Yanfang Y; Chang, Lianpeng L; Xia, Xuefeng X; Li, Lin L; Jia, Shuqin S; Zeng, Qiang Q
Publication Date: 2021-01-04

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 33397889
Variant Present in the following documents:
  • 41467_2020_20162_MOESM6_ESM.xlsx, sheet 1
View BVdb publication page



Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk.

Cancer Research
Silverman, Deborah A DA; Martinez, Vena K VK; Dougherty, Patrick M PM; Myers, Jeffrey N JN; Calin, George A GA; Amit, Moran M
Publication Date: 2021-03-15

Variant appearance in text: p53: A161S
PubMed Link: 33334813
Variant Present in the following documents:
  • Main text
View BVdb publication page



The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study.

Frontiers In Immunology
Punta, Marco M; Jennings, Victoria A VA; Melcher, Alan A AA; Lise, Stefano S
Publication Date: 2020

Variant appearance in text: TP53: A161S
PubMed Link: 33133066
Variant Present in the following documents:
  • Table_6.xlsx, sheet 7
  • Table_1.xlsx, sheet 2
  • Table_6.xlsx, sheet 2
View BVdb publication page



Prospective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Jco Precision Oncology
Pritchett, Michael A MA; Camidge, D Ross DR; Patel, Manu M; Khatri, Jamil J; Boniol, Steven S; Friedman, Elke K EK; Khomani, Abderrahim A; Dalia, Samir S; Baker-Neblett, Katherine K; Plagnol, Vincent V; Howarth, Karen D KD; Jones, Gregory R GR; Rosenfeld, Nitzan N; Morris, Clive D CD; Govindan, Ramaswamy R
Publication Date: 2019

Variant appearance in text: TP53: A161S
PubMed Link: 32914040
Variant Present in the following documents:
  • PO.18.00299.pdf
View BVdb publication page



A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population.

Breast Cancer Research : Bcr
Kang, Taekyu T; Yau, Christina C; Wong, Christopher K CK; Sanborn, John Z JZ; Newton, Yulia Y; Vaske, Charlie C; Benz, Stephen C SC; Krings, Gregor G; Camarda, Roman R; Henry, Jill E JE; Stuart, Josh J; Powell, Mark M; Benz, Christopher C CC
Publication Date: 2020-07-31

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 32736587
Variant Present in the following documents:
  • 13058_2020_1322_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Identification of relevant genetic alterations in cancer using topological data analysis.

Nature Communications
Rabadán, Raúl R; Mohamedi, Yamina Y; Rubin, Udi U; Chu, Tim T; Alghalith, Adam N AN; Elliott, Oliver O; Arnés, Luis L; Cal, Santiago S; Obaya, Álvaro J ÁJ; Levine, Arnold J AJ; Cámara, Pablo G PG
Publication Date: 2020-07-30

Variant appearance in text: TP53: A161S
PubMed Link: 32732999
Variant Present in the following documents:
  • 41467_2020_17659_MOESM3_ESM.xls, sheet 1
View BVdb publication page



Inconsistent Intersample ALK FISH Results in Patients with Lung Cancer: Analysis of Potential Causes.

Cancers
Tang, Zhenya Z; Chen, Hui H; Hong, Lingzhi L; Tang, Guilin G; Toruner, Gokce A GA; Wang, Wei W; Roy Chowdhuri, Sinchita S; Yin, Wei W; Jung, Hai Suk HS; Gu, Jun J; Routbort, Mark J MJ; Zhang, Jianjun J; Khoury, Joseph D JD; Medeiros, L Jeffrey LJ
Publication Date: 2020-07-14

Variant appearance in text: TP53: 481G>T
PubMed Link: 32674491
Variant Present in the following documents:
  • cancers-12-01903.pdf
View BVdb publication page



mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.

Cell Reports
Triki, Mouna M; Rinaldi, Gianmarco G; Planque, Melanie M; Broekaert, Dorien D; Winkelkotte, Alina M AM; Maier, Carina R CR; Janaki Raman, Sudha S; Vandekeere, Anke A; Van Elsen, Joke J; Orth, Martin F MF; Grünewald, Thomas G P TGP; Schulze, Almut A; Fendt, Sarah-Maria SM
Publication Date: 2020-06-23

Variant appearance in text: TP53: A161S
PubMed Link: 32579932
Variant Present in the following documents:
  • mmc5.xlsx, sheet 3
View BVdb publication page



Phase and context shape the function of composite oncogenic mutations.

Nature
Gorelick, Alexander N AN; Sánchez-Rivera, Francisco J FJ; Cai, Yanyan Y; Bielski, Craig M CM; Biederstedt, Evan E; Jonsson, Philip P; Richards, Allison L AL; Vasan, Neil N; Penson, Alexander V AV; Friedman, Noah D ND; Ho, Yu-Jui YJ; Baslan, Timour T; Bandlamudi, Chaitanya C; Scaltriti, Maurizio M; Schultz, Nikolaus N; Lowe, Scott W SW; Reznik, Ed E; Taylor, Barry S BS
Publication Date: 2020-06

Variant appearance in text: TP53: A161S
PubMed Link: 32461694
Variant Present in the following documents:
  • NIHMS1582596-supplement-1582596_Supp_Tab1-5.xlsx, sheet 2
View BVdb publication page



Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material.

Bmc Cancer
Steeghs, Elisabeth M P EMP; Kroeze, Leonie I LI; Tops, Bastiaan B J BBJ; van Kempen, Leon C LC; Ter Elst, Arja A; Kastner-van Raaij, Annemiek W M AWM; Hendriks-Cornelissen, Sandra J B SJB; Hermsen, Mandy J W MJW; Jansen, Erik A M EAM; Nederlof, Petra M PM; Schuuring, Ed E; Ligtenberg, Marjolijn J L MJL; Eijkelenboom, Astrid A
Publication Date: 2020-04-07

Variant appearance in text: TP53: 481G>T; Ala161Ser
PubMed Link: 32264863
Variant Present in the following documents:
  • 12885_2020_6785_MOESM2_ESM.xlsx, sheet 7
View BVdb publication page



Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association
Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H
Publication Date: 2020-07

Variant appearance in text: TP53: A161S
PubMed Link: 32107691
Variant Present in the following documents:
  • 10120_2020_1045_MOESM1_ESM.xlsx, sheet 12
View BVdb publication page



NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis.

Oncogene
Luiken, Sarah S; Fraas, Angelika A; Bieg, Matthias M; Sugiyanto, Raisatun R; Goeppert, Benjamin B; Singer, Stephan S; Ploeger, Carolin C; Warsow, Gregor G; Marquardt, Jens U JU; Sticht, Carsten C; De La Torre, Carolina C; Pusch, Stefan S; Mehrabi, Arianeb A; Gretz, Norbert N; Schlesner, Matthias M; Eils, Roland R; Schirmacher, Peter P; Longerich, Thomas T; Roessler, Stephanie S
Publication Date: 2020-04

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 32055024
Variant Present in the following documents:
  • 41388_2020_1198_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Metabolic Pathways Enhancement Confers Poor Prognosis in p53 Exon Mutant Hepatocellular Carcinoma.

Cancer Informatics
Chen, Po-Ming PM; Li, Jian-Rong JR; Liu, Chun-Chi CC; Tang, Feng-Yao FY; Chiang, En-Pei Isabel EI
Publication Date: 2020

Variant appearance in text: p53: A161S
PubMed Link: 31933519
Variant Present in the following documents:
  • Main text
  • 10.1177_1176935119899913.pdf
View BVdb publication page



Diversity spectrum analysis identifies mutation-specific effects of cancer driver genes.

Communications Biology
Dong, Xiaobao X; Huang, Dandan D; Yi, Xianfu X; Zhang, Shijie S; Wang, Zhao Z; Yan, Bin B; Chung Sham, Pak P; Chen, Kexin K; Jun Li, Mulin M
Publication Date: 2020-01-07

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 31925297
Variant Present in the following documents:
  • 42003_2019_736_MOESM13_ESM.xlsx, sheet 1
  • 42003_2019_736_MOESM4_ESM.xlsx, sheet 1
  • 42003_2019_736_MOESM10_ESM.xlsx, sheet 1
  • 42003_2019_736_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



BRAF Mutation in Colorectal Rhabdoid and Poorly Differentiated Medullary Carcinomas.

Cancers
Bolzacchini, Elena E; Digiacomo, Nunzio N; Marrazzo, Cristina C; Sahnane, Nora N; Maragliano, Roberta R; Gill, Anthony A; Albarello, Luca L; Sessa, Fausto F; Furlan, Daniela D; Capella, Carlo C
Publication Date: 2019-08-26

Variant appearance in text: TP53: A161S
PubMed Link: 31455041
Variant Present in the following documents:
  • Main text
View BVdb publication page



Impact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non-Small-Cell Lung Cancer.

Jco Precision Oncology
Bange, Erin E; Marmarelis, Melina E ME; Hwang, Wei-Ting WT; Yang, Yu-Xiao YX; Thompson, Jeffrey C JC; Rosenbaum, Jason J; Bauml, Joshua M JM; Ciunci, Christine C; Alley, Evan W EW; Cohen, Roger B RB; Langer, Corey J CJ; Carpenter, Erica E; Aggarwal, Charu C
Publication Date: 2019

Variant appearance in text: TP53: A161S
PubMed Link: 31428721
Variant Present in the following documents:
  • Main text
View BVdb publication page



RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling.

Nature Medicine
Yao, Zhan Z; Gao, Yijun Y; Su, Wenjing W; Yaeger, Rona R; Tao, Jessica J; Na, Na N; Zhang, Ying Y; Zhang, Chao C; Rymar, Andrey A; Tao, Anthony A; Timaul, Neilawattie M NM; Mcgriskin, Rory R; Outmezguine, Nathaniel A NA; Zhao, HuiYong H; Chang, Qing Q; Qeriqi, Besnik B; Barbacid, Mariano M; de Stanchina, Elisa E; Hyman, David M DM; Bollag, Gideon G; Rosen, Neal N
Publication Date: 2019-02

Variant appearance in text: TP53: A161S
PubMed Link: 30559419
Variant Present in the following documents:
  • NIHMS1509287-supplement-2.pdf
View BVdb publication page



Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer.

Oncogene
Leong, Tracy L TL; Gayevskiy, Velimir V; Steinfort, Daniel P DP; De Massy, Marc R MR; Gonzalez-Rajal, Alvaro A; Marini, Kieren D KD; Stone, Emily E; Chin, Venessa V; Havryk, Adrian A; Plit, Marshall M; Irving, Louis B LB; Jennings, Barton R BR; McCloy, Rachael A RA; Jayasekara, W Samantha N WSN; Alamgeer, Muhammad M; Boolell, Vishal V; Field, Andrew A; Russell, Prudence A PA; Kumar, Beena B; Gough, Daniel J DJ; Szczepny, Anette A; Ganju, Vinod V; Rossello, Fernando J FJ; Cain, Jason E JE; Papenfuss, Anthony T AT; Asselin-Labat, Marie-Liesse ML; Cowley, Mark J MJ; Watkins, D Neil DN
Publication Date: 2019-03

Variant appearance in text: TP53: 481G>T; Ala161Ser
PubMed Link: 30348992
Variant Present in the following documents:
  • 41388_2018_536_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.

Plos One
Pritchard, Antonia L AL; Johansson, Peter A PA; Nathan, Vaishnavi V; Howlie, Madeleine M; Symmons, Judith J; Palmer, Jane M JM; Hayward, Nicholas K NK
Publication Date: 2018

Variant appearance in text: TP53: 481G>T
PubMed Link: 29641532
Variant Present in the following documents:
  • pone.0194098.s003.xlsx, sheet 2
View BVdb publication page



Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma.

Bmc Cancer
Lu, Hongyang H; Yang, Shifeng S; Zhu, Huineng H; Tong, Xiaoling X; Xie, Fajun F; Qin, Jing J; Han, Na N; Wu, Xue X; Fan, Yun Y; Shao, Yang W YW; Mao, Weimin W
Publication Date: 2018-03-05

Variant appearance in text: TP53: A161S
PubMed Link: 29506494
Variant Present in the following documents:
  • 12885_2018_4159_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma.

Frontiers In Genetics
Kancherla, Venkatesh V; Abdullazade, Samir S; Matter, Matthias S MS; Lanzafame, Manuela M; Quagliata, Luca L; Roma, Guglielmo G; Hoshida, Yujin Y; Terracciano, Luigi M LM; Ng, Charlotte K Y CKY; Piscuoglio, Salvatore S
Publication Date: 2018

Variant appearance in text: TP53: A161S
PubMed Link: 29456550
Variant Present in the following documents:
  • Main text
View BVdb publication page



Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment.

Plos One
Ihle, Michaela Angelika MA; Huss, Sebastian S; Jeske, Wiebke W; Hartmann, Wolfgang W; Merkelbach-Bruse, Sabine S; Schildhaus, Hans-Ulrich HU; Büttner, Reinhard R; Sihto, Harri H; Sundby Hall, Kirsten K; Eriksson, Mikael M; Reichardt, Peter P; Joensuu, Heikki H; Wardelmann, Eva E
Publication Date: 2018

Variant appearance in text: p53: A161S
PubMed Link: 29451912
Variant Present in the following documents:
  • Main text
  • pone.0193048.pdf
View BVdb publication page



Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.

Nature
Yao, Zhan Z; Yaeger, Rona R; Rodrik-Outmezguine, Vanessa S VS; Tao, Anthony A; Torres, Neilawattie M NM; Chang, Matthew T MT; Drosten, Matthias M; Zhao, Huiyong H; Cecchi, Fabiola F; Hembrough, Todd T; Michels, Judith J; Baumert, Hervé H; Miles, Linde L; Campbell, Naomi M NM; de Stanchina, Elisa E; Solit, David B DB; Barbacid, Mariano M; Taylor, Barry S BS; Rosen, Neal N
Publication Date: 2017-08-10

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 28783719
Variant Present in the following documents:
  • Main text
View BVdb publication page



Pan-urologic cancer genomic subtypes that transcend tissue of origin.

Nature Communications
Chen, Fengju F; Zhang, Yiqun Y; Bossé, Dominick D; Lalani, Aly-Khan A AA; Hakimi, A Ari AA; Hsieh, James J JJ; Choueiri, Toni K TK; Gibbons, Don L DL; Ittmann, Michael M; Creighton, Chad J CJ
Publication Date: 2017-08-04

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 28775315
Variant Present in the following documents:
  • 41467_2017_289_MOESM7_ESM.xlsx, sheet 1
View BVdb publication page



AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors.

International Journal Of Molecular Sciences
Casado, Jorge J; Iñigo-Chaves, Almudena A; Jiménez-Ruiz, Sergio M SM; Ríos-Arrabal, Sandra S; Carazo-Gallego, Ángel Á; González-Puga, Cristina C; Núñez, María Isabel MI; Ruíz-Extremera, Ángeles Á; Salmerón, Javier J; León, Josefa J
Publication Date: 2017-06-11

Variant appearance in text: TP53: 481G>T
PubMed Link: 28604612
Variant Present in the following documents:
  • ijms-18-01251-s001.pdf
View BVdb publication page



The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer.

Oncotarget
Coaxum, Sonya D SD; Tiedeken, Jessica J; Garrett-Mayer, Elizabeth E; Myers, Jeffrey J; Rosenzweig, Steven A SA; Neskey, David M DM
Publication Date: 2017-04-04

Variant appearance in text: p53: A161S
PubMed Link: 28160562
Variant Present in the following documents:
  • Main text
  • oncotarget-08-22991.pdf
View BVdb publication page



Frequent amplification of receptor tyrosine kinase genes in welldifferentiated/ dedifferentiated liposarcoma.

Oncotarget
Asano, Naofumi N; Yoshida, Akihiko A; Mitani, Sachiyo S; Kobayashi, Eisuke E; Shiotani, Bunsyo B; Komiyama, Motokiyo M; Fujimoto, Hiroyuki H; Chuman, Hirokazu H; Morioka, Hideo H; Matsumoto, Morio M; Nakamura, Masaya M; Kubo, Takashi T; Kato, Mamoru M; Kohno, Takashi T; Kawai, Akira A; Kondo, Tadashi T; Ichikawa, Hitoshi H
Publication Date: 2017-02-21

Variant appearance in text: TP53: A161S
PubMed Link: 28099935
Variant Present in the following documents:
  • oncotarget-08-12941-s003.xlsx, sheet 1
View BVdb publication page



iFish: predicting the pathogenicity of human nonsynonymous variants using gene-specific/family-specific attributes and classifiers.

Scientific Reports
Wang, Meng M; Wei, Liping L
Publication Date: 2016-08-16

Variant appearance in text: TP53: A161S
PubMed Link: 27527004
Variant Present in the following documents:
  • srep31321-s5.xls, sheet 1
View BVdb publication page



Genetic changes of non-small cell lung cancer under neoadjuvant therapy.

Oncotarget
Warth, Arne A; Endris, Volker V; Stenzinger, Albrecht A; Penzel, Roland R; Harms, Alexander A; Duell, Thomas T; Abdollahi, Amir A; Lindner, Michael M; Schirmacher, Peter P; Muley, Thomas T; Dienemann, Hendrik H; Fink, Ludger L; Morresi-Hauf, Alicia A; Pfarr, Nicole N; Weichert, Wilko W
Publication Date: 2016-05-17

Variant appearance in text: TP53: 481G>T; Ala161Ser
PubMed Link: 27105513
Variant Present in the following documents:
  • oncotarget-07-29761-s002.xlsx, sheet 1
View BVdb publication page



Dynamic changes of driver genes' mutations across clinical stages in nine cancer types.

Cancer Medicine
Li, Xia X
Publication Date: 2016-07

Variant appearance in text: TP53: A161S
PubMed Link: 26992457
Variant Present in the following documents:
  • CAM4-5-1556.pdf
View BVdb publication page



REGene: a literature-based knowledgebase of animal regeneration that bridge tissue regeneration and cancer.

Scientific Reports
Zhao, Min M; Rotgans, Bronwyn B; Wang, Tianfang T; Cummins, S F SF
Publication Date: 2016-03-15

Variant appearance in text: TP53: A161S
PubMed Link: 26975833
Variant Present in the following documents:
  • srep23167-s9.xls, sheet 1
View BVdb publication page



GESPA: classifying nsSNPs to predict disease association.

Bmc Bioinformatics
Khurana, Jay K JK; Reeder, Jay E JE; Shrimpton, Antony E AE; Thakar, Juilee J
Publication Date: 2015-07-25

Variant appearance in text: TP53: A161S
PubMed Link: 26206375
Variant Present in the following documents:
  • 12859_2015_673_MOESM1_ESM.xls, sheet 1
View BVdb publication page



Reactive oxygen species and p21Waf1/Cip1 are both essential for p53-mediated senescence of head and neck cancer cells.

Cell Death & Disease
Fitzgerald, A L AL; Osman, A A AA; Xie, T-X TX; Patel, A A; Skinner, H H; Sandulache, V V; Myers, J N JN
Publication Date: 2015-03-12

Variant appearance in text: TP53: A161S
PubMed Link: 25766317
Variant Present in the following documents:
  • Main text
  • cddis201544a.pdf
View BVdb publication page



Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients.

Cancer Research
Osman, Abdullah A AA; Neskey, David M DM; Katsonis, Panagiotis P; Patel, Ameeta A AA; Ward, Alexandra M AM; Hsu, Teng-Kuei TK; Hicks, Stephanie C SC; McDonald, Thomas O TO; Ow, Thomas J TJ; Alves, Marcus Ortega MO; Pickering, Curtis R CR; Skinner, Heath D HD; Zhao, Mei M; Sturgis, Eric M EM; Kies, Merrill S MS; El-Naggar, Adel A; Perrone, Federica F; Licitra, Lisa L; Bossi, Paolo P; Kimmel, Marek M; Frederick, Mitchell J MJ; Lichtarge, Olivier O; Myers, Jeffrey N JN
Publication Date: 2015-04-01

Variant appearance in text: p53: A161S
PubMed Link: 25691460
Variant Present in the following documents:
  • Main text
View BVdb publication page



Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer.

Cancer Research
Neskey, David M DM; Osman, Abdullah A AA; Ow, Thomas J TJ; Katsonis, Panagiotis P; McDonald, Thomas T; Hicks, Stephanie C SC; Hsu, Teng-Kuei TK; Pickering, Curtis R CR; Ward, Alexandra A; Patel, Ameeta A; Yordy, John S JS; Skinner, Heath D HD; Giri, Uma U; Sano, Daisuke D; Story, Michael D MD; Beadle, Beth M BM; El-Naggar, Adel K AK; Kies, Merrill S MS; William, William N WN; Caulin, Carlos C; Frederick, Mitchell M; Kimmel, Marek M; Myers, Jeffrey N JN; Lichtarge, Olivier O
Publication Date: 2015-04-01

Variant appearance in text: TP53: A161S
PubMed Link: 25634208
Variant Present in the following documents:
  • Main text
View BVdb publication page



Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations.

Genome Biology
Martelotto, Luciano G LG; Ng, Charlotte Ky CK; De Filippo, Maria R MR; Zhang, Yan Y; Piscuoglio, Salvatore S; Lim, Raymond S RS; Shen, Ronglai R; Norton, Larry L; Reis-Filho, Jorge S JS; Weigelt, Britta B
Publication Date: 2014-10-28

Variant appearance in text: TP53: A161S
PubMed Link: 25348012
Variant Present in the following documents:
  • 13059_2014_484_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



The p53-reactivating small molecule RITA induces senescence in head and neck cancer cells.

Plos One
Chuang, Hui-Ching HC; Yang, Liang Peng LP; Fitzgerald, Alison L AL; Osman, Abdullah A; Woo, Sang Hyeok SH; Myers, Jeffrey N JN; Skinner, Heath D HD
Publication Date: 2014

Variant appearance in text: p53: A161S
PubMed Link: 25119136
Variant Present in the following documents:
  • Main text
  • pone.0104821.pdf
View BVdb publication page



Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss.

Nature Genetics
Gross, Andrew M AM; Orosco, Ryan K RK; Shen, John P JP; Egloff, Ann Marie AM; Carter, Hannah H; Hofree, Matan M; Choueiri, Michel M; Coffey, Charles S CS; Lippman, Scott M SM; Hayes, D Neil DN; Cohen, Ezra E EE; Grandis, Jennifer R JR; Nguyen, Quyen T QT; Ideker, Trey T
Publication Date: 2014-09

Variant appearance in text: TP53: 481G>T; A161S
PubMed Link: 25086664
Variant Present in the following documents:
  • NIHMS612904-supplement-2.xlsx, sheet 8
View BVdb publication page



Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing.

Oncotarget
Janku, Filip F; Kaseb, Ahmed O AO; Tsimberidou, Apostolia M AM; Wolff, Robert A RA; Kurzrock, Razelle R
Publication Date: 2014-05-30

Variant appearance in text: TP53: A161S
PubMed Link: 24931142
Variant Present in the following documents:
  • Main text
View BVdb publication page



Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53.

Molecular Cancer Therapeutics
Gadhikar, Mayur A MA; Sciuto, Maria Rita MR; Alves, Marcus Vinicius Ortega MV; Pickering, Curtis R CR; Osman, Abdullah A AA; Neskey, David M DM; Zhao, Mei M; Fitzgerald, Alison L AL; Myers, Jeffrey N JN; Frederick, Mitchell J MJ
Publication Date: 2013-09

Variant appearance in text: p53: A161S
PubMed Link: 23839309
Variant Present in the following documents:
  • Main text
View BVdb publication page



Predicting the functional impact of protein mutations: application to cancer genomics.

Nucleic Acids Research
Reva, Boris B; Antipin, Yevgeniy Y; Sander, Chris C
Publication Date: 2011-09-01

Variant appearance in text: TP53: A161S
PubMed Link: 21727090
Variant Present in the following documents:
  • supp_gkr407_Supplement2_Table_SM1_COSMIC_mutations.xls, sheet 1
View BVdb publication page



Genome-wide analysis to predict protein sequence variations that change phosphorylation sites or their corresponding kinases.

Nucleic Acids Research
Ryu, Gil-Mi GM; Song, Pamela P; Kim, Kyu-Won KW; Oh, Kyung-Soo KS; Park, Keun-Joon KJ; Kim, Jong Hun JH
Publication Date: 2009-03

Variant appearance in text: TP53: A161S
PubMed Link: 19139070
Variant Present in the following documents:
  • gkn1008_nar-01723-s-2008-File009.xls, sheet 2
  • gkn1008_nar-01723-s-2008-File011.xls, sheet 2
  • gkn1008_nar-01723-s-2008-File008.xls, sheet 2
View BVdb publication page